All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
OYST / Oyster Point Pharma Inc
|
|
|
|
|
|
|
|
LXRX / Lexicon Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
LQDA / Liquidia Corporation
|
|
|
|
|
|
|
|
EYRYY / Erytech Pharma
|
|
|
|
|
|
|
|
BE / Bloom Energy Corporation
|
|
|
|
|
|
|
|
DZSI / DZS Inc.
|
|
|
|
|
|
|
|
GLYC / GlycoMimetics, Inc.
|
|
|
|
|
|
|
|
BILL / BILL Holdings, Inc.
|
|
|
|
|
|
|
|
VIRX / Viracta Therapeutics, Inc.
|
|
|
|
|
|
|
|
SPT / Sprout Social, Inc.
|
|
|
|
|
|
|
|
BHG / Bright Health Group, Inc.
|
|
|
|
|
|
|
|
IVA / Inventiva S.A. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
SVRA / Savara Inc.
|
|
|
|
|
|
|
|
VTGN / Vistagen Therapeutics, Inc.
|
|
|
|
|
|
|
|
RGLS / Regulus Therapeutics Inc.
|
|
|
|
|
|
|
|
AFMD / Affimed N.V.
|
|
|
|
|
|
|
|
EAR / Eargo, Inc.
|
|
|
|
|
|
|
|
OPEN / Opendoor Technologies Inc.
|
|
|
|
|
|
|
|
OBSV / ObsEva SA.
|
|
|
|
|
|
|
|
TRVN / Trevena, Inc.
|
|
|
|
|
|
|
|
GRTX / Galera Therapeutics, Inc.
|
|
|
|
|
|
|
|
XENE / Xenon Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
LUMO / Lumos Pharma, Inc.
|
|
|
|
|
|
|
|
AKUS / Akouos Inc
|
|
|
|
|
|
|
|
MEIP / MEI Pharma, Inc.
|
|
|
|
|
|
|
|
MTCR / Metacrine Inc
|
|
|
|
|
|
|
|
CTIC / CTI BioPharma Corp
|
|
|
|
|
|
|
|
STSA / Satsuma Pharmaceuticals Inc
|
|
|
|
|
|
|
|
UPST / Upstart Holdings, Inc.
|
|
|
|
|
|
|
|
CSPR / Casper Sleep Inc
|
|
|
|
|
|
|
|
SBBP / Strongbridge Biopharma plc
|
|
|
|
|
|
|
|
TRIL / Trillium Therapeutics Inc
|
|
|
|
|
|
|
|
IMRA / Bitwise Funds Trust - Bitwise MARA Option Income Strategy ETF
|
|
|
|
|
|
|
|
VECT / VectivBio Holding AG
|
|
|
|
|
|
|
|
MILE / Metromile Inc
|
|
|
|
|
|
|
|
PHAS / PhaseBio Pharmaceuticals Inc
|
|
|
|
|
|
|
|
ARDX / Ardelyx, Inc.
|
|
|
|
|
|
|
|
GNCA / Genocea Biosciences Inc
|
|
|
|
|
|
|
|
ANNX / Annexon, Inc.
|
|
|
|
|
|
|
|
RPHM / Reneo Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
GLUE / Monte Rosa Therapeutics, Inc.
|
|
|
|
|
|
|
|
COUR / Coursera, Inc.
|
|
|
|
|
|
|
|
NET / Cloudflare, Inc.
|
|
|
|
|
|
|
|
TCON / TRACON Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
GERN / Geron Corporation
|
|
|
|
|
|
|
|
MRKR / Marker Therapeutics, Inc.
|
|
|
|
|
|
|
|
TPST / Tempest Therapeutics, Inc.
|
|
|
|
|
|
|
|
AVEO / AVEO Pharmaceuticals Inc
|
|
|
|
|
|
|
|
SYBX / Synlogic, Inc.
|
|
|
|
|
|
|
|
CRSP / CRISPR Therapeutics AG
|
|
|
|
|
|
|
|
CSBR / Champions Oncology, Inc.
|
|
|
|
|
|
|
|
ALLK / Allakos Inc.
|
|
|
|
|
|
|
|
CVRX / CVRx, Inc.
|
|
|
|
|
|
|
|
ADXN / Addex Therapeutics Ltd - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
AKTX / Akari Therapeutics, Plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
AUPH / Aurinia Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
NKTX / Nkarta, Inc.
|
|
|
|
|
|
|
|
RYTM / Rhythm Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
BDTX / Black Diamond Therapeutics, Inc.
|
|
|
|
|
|
|
|
MIRM / Mirum Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
INZY / Inozyme Pharma, Inc.
|
|
|
|
|
|
|
|
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
DM / Desktop Metal, Inc.
|
|
|
|
|
|
|
|
TRVI / Trevi Therapeutics, Inc.
|
|
|
|
|
|
|
|